AGC Biologics Inc.
EIR issued February 10, 2023 · Bothell, Washington
- Investigators
- Andrew K. Haack· Brian M. Janelsins· Michael Araneta
- Pages
- 94
- FEI number
- 3000209996
In short: This is FDA's Establishment Inspection Report (EIR) for AGC Biologics Inc. in Bothell, Washington (FEI 3000209996). It is the investigator's full narrative of what they examined, who they spoke to and what they found. The investigators were Andrew K. Haack, Brian M. Janelsins and Michael Araneta.
Inside this inspection report
The investigator's narrative
The full inspection report: what the investigator looked at, who they spoke to and what they found, in their own words.
Get the full EIRThis inspection in context
Andrew K. Haack
12 documents · 2017–2023
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Washington.
The firmAGC Biologics Inc. history
All 8 documents on file for this site, in date order, with what was cited at each inspection.
Similar documentsMore eirs
Browse other documents of this type.
Questions about this EIR
Who inspected AGC Biologics Inc.?
Andrew K. Haack, Brian M. Janelsins and Michael Araneta are named on this EIR. Each investigator has a profile showing what they cite most.
When was AGC Biologics Inc. inspected by FDA?
This EIR is dated February 10, 2023.
How do I get the full EIR for AGC Biologics Inc.?
Download the original PDF from FDA Intel for $550, with no subscription. You also get an invoice PDF with the order.